{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-029599","form_type":"8-K","ticker":"SCYX","cik":"0001178253","company_name":"SCYNEXIS INC","filed_at":"2023-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.155595+00:00","generated_at":"2026-06-13T17:38:50.583874+00:00","sec_items":["1.02","8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"SCYNEXIS terminates $35M loan with Hercules/SVB after GSK deal; receives $25M milestone; clarifies equity vote","bullets":["Terminated $35M Loan and Security Agreement with Hercules Capital and SVB on May 25, 2023, after receiving upfront payment from GSK license.","Announced $25M performance milestone from GSK on June 21, 2023, for Phase 3 MARIO study of ibrexafungerp.","Due to proxy statement ambiguity on broker non-votes, SCYNEXIS deemed 2023 Equity Incentive Plan vote not approved; will use 2014 plan and reintroduce in 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-029599","json":"https://secwatch.observer/filing/0000950170-23-029599.json","markdown":"https://secwatch.observer/filing/0000950170-23-029599.md","text":"https://secwatch.observer/filing/0000950170-23-029599.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178253/000095017023029599/0000950170-23-029599-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178253/000095017023029599/scyx-20230525.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T17:38:50.583874+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5e1b1f36ccb46ae99c8886d6eddd24544c732f3c","claim":"SCYNEXIS INC terminated Loan and Security Agreement with Hercules Capital, Inc. and Silicon Valley Bridge Bank, N.A. valued at $35 million (effective 2023-05-25).","evidence_excerpt":"Item 1.02 Termination of a Material Definitive Agreement. SCYNEXIS, Hercules Capital, Inc. (“Hercules Capital”) and Silicon Valley Bridge Bank, N.A. (“SVB”) were party to a Loan and Security Agreement dated as of May 13, 2021 (the “Loan Agreement”), pursuant to which Hercules Capital, SVB and each of the other lenders from time-to-time party to the Loan and Security Agreement (collectively, the “Lenders”) loaned to SCYNEXIS $35 million.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1178253/000095017023029599/0000950170-23-029599-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Hercules Capital, Inc. and Silicon Valley Bridge Bank, N.A."},{"label":"Value","value":"$35 million"},{"label":"Effective","value":"2023-05-25"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}